AmyT

Much Ado About Januvia: What It Doesn’t Do

Lots of press recently about Merck’s brand spankin’ new Type 2 diabetes drug, Januvia. Patients seem to like it. The EU likes it. So Wall Street likes it, too.  What is so wonderful about this new oral with the Shakespearean name?
Here’s what I found out, explained from my extremely laymen’s point-of-view:
In addition to insulin, our bodies release certain “incretin hormones” called GLP-1 and GIP.  In a healthy body, the ideal amount is released…

Read more »

My “True Life Story” in 3.6 Minutes

OK, time to come clean.  The other thing I was doing on my recent trip to New York was visiting with a dynamic new company called HealthiNation (pronounced healthY-nation).  This group is busy creating the first “on-demand health video network,” i.e. a series of informative and instructional videos that help “everyday people” understand the complexities of all sorts of health issues and medical disorders. Viewers can purchase the videos directly off the website, or pick…

Read more »

A Few Products I Like

It’s a plug fest, folks, but only because I am somehow personally passionate about these items:
1) I wrote about a neat new protective case for Lantus vials recently.  Well now a reader tipped me off to a similar one, available on eBay, apparently designed by a mother whose son wouldn’t let her wrap his bottles of insulin with bubble wrap (not cool, mom! they note). This one looks pretty cool
2) Have you all…

Read more »

Hypo School

I have been schooled in hypoglycemia, in more ways than one.
TYPE 2) First off, you were all right, of course: hypoglycemia is apparently often an early sign of Type 2 diabetes.
Excerpts from Connie Bennett’s new carb-bashing book, Sugar Shock!, cleared this right up:
When the body is resistant to the insulin it makes, the result is “… an ‘overshoot’ phenomenon characterized by a large spike in insulin, followed by a drop in blood…

Read more »

PharmedOut

Down on Big Pharma?  You are not alone.  Whether or not you actually believe that these companies are suppressing a cure for diabetes in order to stay in business, you probably have some (well-founded) suspicions about ethics in medical practice.
So you might be as intrigued as I was to discover the existence of PharmedOut, an independent, publicly-funded (!) project (hat tip: Pharma Gossip) that “empowers physicians to identify and counter inappropriate pharmaceutical promotion practices.”…

Read more »